187 related articles for article (PubMed ID: 12074328)
1. Mammographically detected breast cancers and the risk of axillary lymph node involvement: is it just the tumor size?
Heimann R; Munsell M; McBride R
Cancer J; 2002; 8(3):276-81. PubMed ID: 12074328
[TBL] [Abstract][Full Text] [Related]
2. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes.
Fein DA; Fowble BL; Hanlon AL; Hooks MA; Hoffman JP; Sigurdson ER; Jardines LA; Eisenberg BL
J Surg Oncol; 1997 May; 65(1):34-9. PubMed ID: 9179265
[TBL] [Abstract][Full Text] [Related]
3. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
[TBL] [Abstract][Full Text] [Related]
4. The role of axillary dissection in mammographically detected carcinoma.
Pandelidis SM; Peters KL; Walusimbi MS; Casady RL; Laux SV; Cavanaugh SH; Bauer TL
J Am Coll Surg; 1997 Apr; 184(4):341-5. PubMed ID: 9100677
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
[TBL] [Abstract][Full Text] [Related]
6. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
Greco M; Crippa F; Agresti R; Seregni E; Gerali A; Giovanazzi R; Micheli A; Asero S; Ferraris C; Gennaro M; Bombardieri E; Cascinelli N
J Natl Cancer Inst; 2001 Apr; 93(8):630-5. PubMed ID: 11309439
[TBL] [Abstract][Full Text] [Related]
7. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?
Chua B; Ung O; Taylor R; Boyages J
ANZ J Surg; 2002 Nov; 72(11):786-92. PubMed ID: 12437688
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
[TBL] [Abstract][Full Text] [Related]
10. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
11. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
[TBL] [Abstract][Full Text] [Related]
12. Cancer in the augmented breast. Diagnosis and prognosis.
Clark CP; Peters GN; O'Brien KM
Cancer; 1993 Oct; 72(7):2170-4. PubMed ID: 8374874
[TBL] [Abstract][Full Text] [Related]
13. Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection.
Dees EC; Shulman LN; Souba WW; Smith BL
Ann Surg; 1997 Sep; 226(3):279-86; discussion 286-7. PubMed ID: 9339934
[TBL] [Abstract][Full Text] [Related]
14. The benefits of mammography are not limited to women of ages older than 50 years.
Heimann R; Bradley J; Hellman S
Cancer; 1998 Jun; 82(11):2221-6. PubMed ID: 9610702
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers.
Gajdos C; Tartter PI; Bleiweiss IJ
Ann Surg; 1999 Nov; 230(5):692-6. PubMed ID: 10561094
[TBL] [Abstract][Full Text] [Related]
16. Axillary node metastasis from T1N0M0 breast cancer: possible avoidance of dissection in a subgroup.
Iwasaki Y; Fukutomi T; Akashi-Tanaka S; Nanasawa T; Tsuda H
Jpn J Clin Oncol; 1998 Oct; 28(10):601-3. PubMed ID: 9839499
[TBL] [Abstract][Full Text] [Related]
17. [Axillary lymph node dissection in clinically occult breast cancer].
Le Bouëdec G; Pomel C; Chamussy E; Feillel V; de Latour M; Dauplat J
Bull Cancer; 1996 Jul; 83(7):581-8. PubMed ID: 8868947
[TBL] [Abstract][Full Text] [Related]
18. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
19. Clinically occult breast carcinoma: diagnostic approaches and role of axillary node dissection.
Meterissian S; Fornage BD; Singletary SE
Ann Surg Oncol; 1995 Jul; 2(4):314-8. PubMed ID: 7552620
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Invasive Breast Cancer Detected by Digital Breast Tomosynthesis on Screening and Diagnostic Mammograms.
Baydoun SE; Yang L; Xiong J; Fajardo LL
Can Assoc Radiol J; 2021 May; 72(2):242-250. PubMed ID: 32062995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]